These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Predictions and Statistics for the Best-Selling Drugs Globally and in the United States in 2018 and a Look Forward to 2024 Projections. Lindsley CW ACS Chem Neurosci; 2019 Mar; 10(3):1115. PubMed ID: 30889957 [No Abstract] [Full Text] [Related]
8. Strategies for developing and commercializing nanobio drugs, diagnostics and devices. Bunger M Nanomedicine (Lond); 2007 Apr; 2(2):137-41. PubMed ID: 17716115 [No Abstract] [Full Text] [Related]
9. Pharmaceutical industry financial performance. Goodman M Nat Rev Drug Discov; 2009 Dec; 8(12):927-8. PubMed ID: 19949398 [No Abstract] [Full Text] [Related]
10. Can complexity be commercialized? Mack GS Nat Biotechnol; 2004 Oct; 22(10):1223-9. PubMed ID: 15470456 [No Abstract] [Full Text] [Related]
11. Sales from licensed and acquired products to increase by 2013. Goodman M Nat Rev Drug Discov; 2009 Jun; 8(6):443. PubMed ID: 19483704 [No Abstract] [Full Text] [Related]
12. Trading on traditional medicines. Basu P Nat Biotechnol; 2004 Mar; 22(3):263-5. PubMed ID: 14990941 [No Abstract] [Full Text] [Related]
13. US drug sales continue to rise. Gottlieb S BMJ; 2003 Mar; 326(7388):518. PubMed ID: 12623895 [No Abstract] [Full Text] [Related]
14. Assessment of the opportunities for pharmaceutical manufacturers in emerging markets. Anderson T; Olson J; Sobelman D J Manag Care Pharm; 2009 Jun; 15(5):396-402. PubMed ID: 19496636 [No Abstract] [Full Text] [Related]
15. Why are we Being Overcharged for Pharmaceuticals? What Should We Do About It? Hyman DA; Silver C J Leg Med; 2019; 39(2):137-149. PubMed ID: 31503533 [No Abstract] [Full Text] [Related]
16. Pharmaceuticals and medical devices: business practices. ; Steiner DJ Issue Brief Health Policy Track Serv; 2014 Dec; ():1-38. PubMed ID: 25771555 [No Abstract] [Full Text] [Related]
17. How insurers' bargaining power affects drug prices in Medicare Part D. Natl Bur Econ Res Bull Aging Health; 2009; (4):1-2. PubMed ID: 20355274 [No Abstract] [Full Text] [Related]
18. [The Brazilian pharmaceutical industry and foreign trade: is there evidence of regressive specialization?]. Mota FB; Cassiolato JE; Gadelha CA Cad Saude Publica; 2012 Mar; 28(3):527-36. PubMed ID: 22415185 [TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical forecasting: throwing darts? Cha M; Rifai B; Sarraf P Nat Rev Drug Discov; 2013 Oct; 12(10):737-8. PubMed ID: 24080692 [No Abstract] [Full Text] [Related]